OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
HYG$7.0055

Seneca Growth Capital VCT PLC

Investment Management & Fund OperatorsVerified

Seneca Growth Capital VCT PLC has a market price of £7.00 and a market capitalization of £56,807,632, with no dilution risk identified based on the current share structure. The company's liquidity risk remains unassessed due to the absence of balance-sheet inputs and going-concern language in the source documents. The company's profitability and returns are not directly quantifiable in the valuation snapshot, as it operates as a venture capital trust with a focus on long-term capital appreciation and income generation. The absence of traditional profitability metrics such as EBITDA or net income limits direct comparison to industry peers. Seneca Growth Capital VCT PLC's portfolio is diversified across multiple sectors, including business services, pharma/biopharma, software, health and consumer, retail, and manufacturing. The geographic exposure is primarily UK-based, with investments in both AIM-quoted and unquoted companies. The company's growth trajectory is not explicitly quantified in the input data, but its investment strategy suggests a long-term horizon. The absence of historical revenue data prevents a detailed growth analysis. The risk assessment indicates low dilution potential, with no near-term pressure identified. However, the lack of liquidity risk assessment introduces uncertainty regarding the company's ability to meet short-term obligations. Recent events and filings have not been disclosed in the input data, limiting the ability to assess any material developments that may impact the company's operations or valuation.

30-day price · HYG(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanySeneca Growth Capital VCT PLC
TickerHYG.L
SectorFinancials
BusinessBanking & Investment Services
Industry groupBanking & Investment Services
IndustryInvestment Management & Fund Operators
AI analysis

Business. Seneca Growth Capital VCT PLC is a United Kingdom-based venture capital trust that invests in a portfolio of unquoted and AIM/AQSE-quoted UK companies to provide shareholders with income and capital returns.

Classification. Seneca Growth Capital VCT PLC is classified under the Financials sector, specifically in the Investment Management & Fund Operators industry, with a confidence level of 0.92.

Seneca Growth Capital VCT PLC has a market price of £7.00 and a market capitalization of £56,807,632, with no dilution risk identified based on the current share structure. The company's liquidity risk remains unassessed due to the absence of balance-sheet inputs and going-concern language in the source documents. The company's profitability and returns are not directly quantifiable in the valuation snapshot, as it operates as a venture capital trust with a focus on long-term capital appreciation and income generation. The absence of traditional profitability metrics such as EBITDA or net income limits direct comparison to industry peers. Seneca Growth Capital VCT PLC's portfolio is diversified across multiple sectors, including business services, pharma/biopharma, software, health and consumer, retail, and manufacturing. The geographic exposure is primarily UK-based, with investments in both AIM-quoted and unquoted companies. The company's growth trajectory is not explicitly quantified in the input data, but its investment strategy suggests a long-term horizon. The absence of historical revenue data prevents a detailed growth analysis. The risk assessment indicates low dilution potential, with no near-term pressure identified. However, the lack of liquidity risk assessment introduces uncertainty regarding the company's ability to meet short-term obligations. Recent events and filings have not been disclosed in the input data, limiting the ability to assess any material developments that may impact the company's operations or valuation.
Key takeaways
  • Seneca Growth Capital VCT PLC is a UK-based venture capital trust with a focus on unquoted and AIM-quoted UK companies.
  • The company's market capitalization is £56.8 million, with no dilution risk identified.
  • The portfolio is diversified across multiple sectors, including business services, pharma/biopharma, and software.
  • The company's liquidity risk remains unassessed due to the absence of balance-sheet inputs.
  • The investment strategy suggests a long-term horizon, but historical revenue data is not available for growth analysis.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyGBP
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$7.00
Market cap$56.8M
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Banking & Investment Services · cohort 10 companies
MetricHYGActivity
Op margin26.6% medp25 13.9% · p75 29.0%
Net margin18.8% medp25 13.7% · p75 22.7%
Gross margin67.6% medp25 41.5% · p75 93.2%
CapEx / revenue1.2% medp25 0.4% · p75 1.9%
Debt / equity7.7% medp25 7.7% · p75 7.7%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 18:39 UTC#66d1b909
Market quoteclose GBP 7.00 · shares 0.01B diluted
no public URL
2026-05-04 18:39 UTC#f56199a8
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 18:40 UTCJob: 9e2c3b00